EconomyAstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan

AstraZeneca’s third-quarter net profit rose 23% on strong cancer-drug sales. The British drugmaker plans to save $1.5 billion (€1.34 billion) annually and reinvest the funds in developing new medicines.

AstraZenecaquarterly earningscancer drugscost savings

Eeuronews★★☆☆☆2026-10-30 12:17Original